We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

173 hedge funds and large institutions have $1.62B invested in Cardiovascular Systems, Inc. in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 66 increasing their positions, 63 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more call options, than puts

Call options by funds: $4.55M | Put options by funds: $1.02M

12% more capital invested

Capital invested by funds: $1.44B → $1.62B (+$179M)

5% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 63

1% less funds holding

Funds holding: 174173 (-1)

5% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 19

Holders
173
Holders Change
-1
Holders Change %
-0.57%
% of All Funds
3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
66
Reduced
63
Closed
19
Calls
$4.55M
Puts
$1.02M
Net Calls
+$3.52M
Net Calls Change
+$3.98M

CSII Hedge Fund Activity: Q2 2021 in Review

173 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2021, worth a combined $1.62B — up 12% from $1.44B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of CSII and 18 opened new positions — a net loss of 1 holder — while 63 trimmed existing stakes and 66 added.

The largest buyer was JP Morgan Chase, adding an estimated $13.4M. The largest seller was Frontier Capital Management, exiting entirely with an estimated $7.43M sold.

  • 173 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2021, down from 174 in Q1 2021.
  • Funds reported $1.62B of Cardiovascular Systems, Inc. stock for Q2 2021, up 12% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q2 2021 and 19 closed out, a net change of -1 holder.
  • The largest Cardiovascular Systems, Inc. buyer in Q2 2021 was JP Morgan Chase, an estimated $13.4M added.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2021 was Frontier Capital Management, an estimated $7.43M sold.

Based on aggregated 13F filings for Q2 2021.